Publications 

Defining Postoperative Success - At times, what defines post-operative success can differ between the patient and the physician. A panel of physicians share their process of managing patient expectations with the canaloplasty procedure.

In addition to its role in the treatment of mild-moderate glaucoma, canaloplasty (iTrack, Nova Eye) also offers considerable utility in the treatment of severe glaucoma. In this roundtable discussion, a panel of physicians discuss how they’ve integrated canaloplasty for their patients across the entire disease spectrum.

One of the many benefits of canaloplasty (iTrack, Nova Eye) is its versatility: it offers a highly effective treatment option both with and without cataract surgery, in all grades of glaucoma severity, and in cases of controlled and uncontrolled glaucoma. A panel of physicians discuss the factors which brought this procedure into their wheelhouse, the various techniques used for different patients, and more.

A panel of physicians share their experience and success performing canaloplasty (iTrack, Nova Eye) as a standalone procedure for pseudophakic patients. The group shares surgical pearls, tips for patient selection, and more.

Why are more and more surgeons turning to canaloplasty for the treatment of their mild-moderate glaucoma patients? 

James T. Murphy, MD, describes the case of a 44-year-old woman who was referred to his office for evaluation of IOP elevation following her second injection of a dexamethasone intravitreal implant

Combining MIGS procedures is something James Murphy, MD, considers if he wants to get the most IOP-lowering effect balanced with a minimal surgical risk profile